Report cover image

Single-Use Bioreactors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Publisher IMARC Services Pvt. Ltd.
Published May 29, 2023
Length 175 Pages
SKU # IMRC17986293

Description

Single-Use Bioreactors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


The global single-use bioreactors market size reached US$ 2.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.

A single-use bioreactor (SUB), also known as a disposable bioreactor, relies on a disposable bag instead of a culture vessel made using stainless steel or glass. It is flexible and easy to use and install, and requires fewer utility requirements, including steam and water. Besides this, it reduces labor costs, minimizes the risk of cross-contamination, and eliminates the cleaning process and validation issue. As a result, it finds extensive applications in contract research organizations (CROs) and contract manufacturing organizations (CMOs) worldwide.

Single-Use Bioreactors Market Trends:



SUBs are employed in the pharmaceutical industry for media and buffer preparation, cell harvesting, filtration, purification, and virus inactivation. They are also used in academic and commercial-scale laboratories for drug discovery, biofuel manufacturing, and the development of vaccines and antibodies. This, in confluence with the burgeoning biopharmaceutical industry, represents one of the key factors impelling the growth of the market. Moreover, autoclaving a conventional bioreactor can become a lengthy, costly, and inconsistent pharmaceutical manufacturing process. However, SUBs utilize presterilized bioprocess bags and consequently reduce the additional costs and time of sterilization. Besides this, as they have fewer moving parts than conventional bioreactors, SUBs are less expensive to maintain. Apart from this, SUBs have a lower overall impact on the environment compared to stainless steel equipment. This, coupled with the growing number of clinical trials around the world, is catalyzing their demand across the globe. Furthermore, leading players are increasingly focusing on product innovations and mergers and acquisitions (M&A) to expand their customer base and increase their geographical presence. This, along with the rising adoption of single-use technology (SUT), is augmenting the overall sales and profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global single-use bioreactors market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, type, cell type, molecule type and end user.

Breakup by Product Type:

Single-use Bioreactor Systems

Media Bags

Filtration Assemblies

Others

Breakup by Type:

Stirred-tank Bioreactors

Wave-induced Bioreactors

Bubble-column Bioreactors

Others

Breakup by Cell Type:

Mammalian Cell

Bacteria

Yeast

Others

Breakup by Molecule Type:

Vaccines

Monoclonal Antibodies

Stem Cells

Recombinant Proteins

Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Contract Research Organizations

Academic and Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ABEC Inc., Cellexus, Celltainer Biotech B.V., CESCO Bioengineering Co. Ltd., Distek Inc., Eppendorf SE, General Electric Company, Getinge AB, Merck KGaA, Pall Corporation (Danaher Corporation), PBS Biotech Inc., Sartorius AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. What was the size of the global single-use bioreactors market in 2022?

2. What is the expected growth rate of the global single-use bioreactors market during 2023-2028?

3. What are the key factors driving the global single-use bioreactors market?

4. What has been the impact of COVID-19 on the global single-use bioreactors market?

5. What is the breakup of the global single-use bioreactors market based on the product type?

6. What is the breakup of the global single-use bioreactors market based on the type?

7. What is the breakup of the global single-use bioreactors market based on the cell type?

8. What is the breakup of the global single-use bioreactors market based on the molecule type?

9. What are the key regions in the global single-use bioreactors market?

10. Who are the key players/companies in the global single-use bioreactors market?

Table of Contents

175 Pages
1 Preface
2 Scope and Methodology
  2.1 Objectives of the Study
  2.2 Stakeholders
  2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
  2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
  2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
  4.1 Overview
  4.2 Key Industry Trends
5 Global Single-use Bioreactor Market
  5.1 Market Overview
  5.2 Market Performance
  5.3 Impact of COVID-19
  5.4 Market Forecast
6 Market Breakup by Product Type
  6.1 Single-use Bioreactor Systems
6.1.1 Market Trends
6.1.2 Market Forecast
  6.2 Media Bags
6.2.1 Market Trends
6.2.2 Market Forecast
  6.3 Filtration Assemblies
6.3.1 Market Trends
6.3.2 Market Forecast
  6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Type
  7.1 Stirred-tank Bioreactors
7.1.1 Market Trends
7.1.2 Market Forecast
  7.2 Wave-induced Bioreactors
7.2.1 Market Trends
7.2.2 Market Forecast
  7.3 Bubble-column Bioreactors
7.3.1 Market Trends
7.3.2 Market Forecast
  7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Cell Type
  8.1 Mammalian Cells
8.1.1 Market Trends
8.1.2 Market Forecast
  8.2 Bacteria
8.2.1 Market Trends
8.2.2 Market Forecast
  8.3 Yeast
8.3.1 Market Trends
8.3.2 Market Forecast
  8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Molecule Type
  9.1 Vaccines
9.1.1 Market Trends
9.1.2 Market Forecast
  9.2 Monoclonal Antibodies
9.2.1 Market Trends
9.2.2 Market Forecast
  9.3 Stem Cells
9.3.1 Market Trends
9.3.2 Market Forecast
  9.4 Recombinant Proteins
9.4.1 Market Trends
9.4.2 Market Forecast
  9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10  Market Breakup by End User
  10.1 Pharmaceutical and Biopharmaceutical Companies
10.1.1 Market Trends
10.1.2 Market Forecast
  10.2 Contract Research Organizations
10.2.1 Market Trends
10.2.2 Market Forecast
  10.3 Academic and Research Institutes
10.3.1 Market Trends
10.3.2 Market Forecast
  10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11  Market Breakup by Region
  11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
  11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
  11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
  11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
  11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12  SWOT Analysis
  12.1 Overview
  12.2 Strengths
  12.3 Weaknesses
  12.4 Opportunities
  12.5 Threats
13  Value Chain Analysis
14  Porters Five Forces Analysis
  14.1 Overview
  14.2 Bargaining Power of Buyers
  14.3 Bargaining Power of Suppliers
  14.4 Degree of Competition
  14.5 Threat of New Entrants
  14.6 Threat of Substitutes
15  Price Analysis
16  Competitive Landscape
  16.1 Market Structure
  16.2 Key Players
  16.3 Profiles of Key Players
16.3.1 ABEC Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Cellexus
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Celltainer Biotech B.V.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 CESCO Bioengineering Co. Ltd.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Distek Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Eppendorf SE
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 SWOT Analysis
16.3.7 General Electric Company
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Getinge AB
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Merck KGaA
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Pall Corporation (Danaher Corporation)
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 SWOT Analysis
16.3.11 PBS Biotech Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 Sartorius AG
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Thermo Fisher Scientific Inc.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us